Wakako Fukuda1, Mari Chiyoya1, Satoshi Taniguchi1, Kazuyuki Daitoku1, Ikuo Fukuda2. 1. Department of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. 2. Department of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. ikuofuku@hirosaki-u.ac.jp.
Abstract
PURPOSE: The risk of venous thromboembolism (VTE) is high during pregnancy. Although most patients with VTE are safely treated via medications, the optimal treatment for massive pulmonary embolism remains controversial. To evaluate the safety and efficacy of VTE management during pregnancy, we report our single center experience of treating VTE in pregnant women. METHODS: Case records were retrospectively reviewed from seven patients who underwent treatment for venous thromboembolism between 2002 and 2014. RESULTS: Mean gestational time was 28 ± 6.2 weeks. Four patients with deep vein thrombosis were treated medically, and they all had vaginal delivery at full term without hemorrhagic complication. Three patients with massive pulmonary embolism underwent surgical embolectomy. Two of these three patients underwent cesarean delivery at 28 and 29 weeks respectively. There was no maternal death, but one fetal death occurred during surgical embolectomy. CONCLUSION: VTE during pregnant women is safely managed by anticoagulant therapy. Massive pulmonary embolism during pregnancy can be managed safely by surgical embolectomy using cardiopulmonary bypass, but the rate of fetal loss remains high.
PURPOSE: The risk of venous thromboembolism (VTE) is high during pregnancy. Although most patients with VTE are safely treated via medications, the optimal treatment for massive pulmonary embolism remains controversial. To evaluate the safety and efficacy of VTE management during pregnancy, we report our single center experience of treating VTE in pregnant women. METHODS: Case records were retrospectively reviewed from seven patients who underwent treatment for venous thromboembolism between 2002 and 2014. RESULTS: Mean gestational time was 28 ± 6.2 weeks. Four patients with deep vein thrombosis were treated medically, and they all had vaginal delivery at full term without hemorrhagic complication. Three patients with massive pulmonary embolism underwent surgical embolectomy. Two of these three patients underwent cesarean delivery at 28 and 29 weeks respectively. There was no maternal death, but one fetal death occurred during surgical embolectomy. CONCLUSION:VTE during pregnant women is safely managed by anticoagulant therapy. Massive pulmonary embolism during pregnancy can be managed safely by surgical embolectomy using cardiopulmonary bypass, but the rate of fetal loss remains high.
Authors: Marjan Jahangiri; James Clarke; Federico Prefumo; Charles Pumphrey; David Ward; James Clark Journal: J Thorac Cardiovasc Surg Date: 2003-09 Impact factor: 5.209
Authors: Kiran Yalamanchili; Arlen G Fleisher; Stuart G Lehrman; Howard I Axelrod; Rocco J Lafaro; Mohan R Sarabu; Elias A Zias; Richard A Moggio Journal: Ann Thorac Surg Date: 2004-03 Impact factor: 4.330
Authors: Hyeran Kang; Yoon Mi Shin; Sang Min Kim; Yook Kim; Laura Adelaide Dalla Vecchia; Kwok Ming Ho Journal: J Thorac Dis Date: 2019-04 Impact factor: 2.895